000 02017cam a2200349 a 4500
003 EG-GiCUC
005 20250223030757.0
008 130225s2012 ua dh f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aPh.D
099 _aCai01.11.27.Ph.D.2012.Da.H
100 0 _aDalia Nabil Abdelhafez Mostafa
245 1 0 _aHER - 2 / neu , estrogen and progesterone receptors expression in endometrial carcinoma :
_bHistopathological and immunohistochemical study /
_cDalia Nabil Abdelhafez Mostafa ; Supervised Nour Elhoda Sayed Ismael , Mona Anwar Abdelhameed , Samar Abdelmoneim Alsheikh
246 1 5 _aالتعبير عن مستقبلات الهر - 2 - نيو : الاستروجين والبروجستيرون فى سرطان بطانة الرحم :
_bدراسة هستوباثولوجية ونسيجية كيميائية مناعية
260 _aCairo :
_bDalia Nabil Abdelhafez Mostafa ,
_c2012
300 _a151P. :
_bcharts , facsimiles ;
_c25cm
502 _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Pathology
520 _aEndometrial carcinoma (EC) is the most common malignancy of the female genital tract . Estrogen recptors (ERs) and Progesterone receptors (PRs) are generally decreased in endometrial carcnoma compared to endometrial hyperplasia and the loss of receptors is a part of carcinogenesis of the endometrium . The human HER 2 neu (c-erbB-2)plays an important role in coordinating the endometrial growth factor receptor signaling network
530 _aIssued also as CD
653 4 _aEndometrial carcinoma (EC)
653 4 _aEstrogen recptors (ER)
653 4 _aProgesterone receptors (PR)
700 0 _aMona Anwar Abdelhameed ,
_eSupervisor
700 0 _aNour Elhoda Sayed Ismael ,
_eSupervisor
700 0 _aSamar Abdelmoneim Alsheikh ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
905 _aFatma
_eCataloger
905 _aNazla
_eRevisor
942 _2ddc
_cTH
999 _c41712
_d41712